These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 37815053)

  • 41. Low-density lipoprotein particle size, triglycerides, and high-density lipoprotein cholesterol as risk factors for coronary heart disease in older Japanese-American men.
    Austin MA; Rodriguez BL; McKnight B; McNeely MJ; Edwards KL; Curb JD; Sharp DS
    Am J Cardiol; 2000 Aug; 86(4):412-6. PubMed ID: 10946034
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Triglycerides and small dense low density lipoprotein in the discrimination of coronary heart disease risk in South Asian populations.
    Patel JV; Caslake MJ; Vyas A; Cruickshank JK; Prabhakaran D; Bhatnagar D; Reddy KS; Lip GY; Mackness MI; Hughes EA; Durrington PN
    Atherosclerosis; 2010 Apr; 209(2):579-84. PubMed ID: 19922937
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Apolipoprotein Proteomics for Residual Lipid-Related Risk in Coronary Heart Disease.
    Clarke R; Von Ende A; Schmidt LE; Yin X; Hill M; Hughes AD; Pechlaner R; Willeit J; Kiechl S; Watkins H; Theofilatos K; Hopewell JC; Mayr M;
    Circ Res; 2023 Feb; 132(4):452-464. PubMed ID: 36691918
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lipoproteins in the DCCT/EDIC cohort: associations with diabetic nephropathy.
    Jenkins AJ; Lyons TJ; Zheng D; Otvos JD; Lackland DT; McGee D; Garvey WT; Klein RL;
    Kidney Int; 2003 Sep; 64(3):817-28. PubMed ID: 12911531
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Relationship between Apolipoprotein E Genotype and Lipoprotein Profile in Patients with Coronary Heart Disease.
    Lin Y; Yang Q; Liu Z; Su B; Xu F; Li Y; Kang J; Zhou Z
    Molecules; 2022 Feb; 27(4):. PubMed ID: 35209166
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical utility of different lipid measures for prediction of coronary heart disease in men and women.
    Ingelsson E; Schaefer EJ; Contois JH; McNamara JR; Sullivan L; Keyes MJ; Pencina MJ; Schoonmaker C; Wilson PW; D'Agostino RB; Vasan RS
    JAMA; 2007 Aug; 298(7):776-85. PubMed ID: 17699011
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Relation of plasma levels and composition of apolipoprotein B-containing lipoproteins to angiographically defined coronary artery disease in young patients with myocardial infarction.
    Tornvall P; Båvenholm P; Landou C; de Faire U; Hamsten A
    Circulation; 1993 Nov; 88(5 Pt 1):2180-9. PubMed ID: 8222113
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Apolipoprotein C-III, a strong discriminant of coronary risk in men and a determinant of the metabolic syndrome in both genders.
    Onat A; Hergenç G; Sansoy V; Fobker M; Ceyhan K; Toprak S; Assmann G
    Atherosclerosis; 2003 May; 168(1):81-9. PubMed ID: 12732390
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Action of atorvastatin in combined hyperlipidemia : preferential reduction of cholesteryl ester transfer from HDL to VLDL1 particles.
    Guerin M; Lassel TS; Le Goff W; Farnier M; Chapman MJ
    Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):189-97. PubMed ID: 10634817
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study.
    Sharrett AR; Ballantyne CM; Coady SA; Heiss G; Sorlie PD; Catellier D; Patsch W;
    Circulation; 2001 Sep; 104(10):1108-13. PubMed ID: 11535564
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E.
    Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
    Biochim Biophys Acta; 2000 Feb; 1484(1):29-40. PubMed ID: 10685028
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Primary aldosteronism is associated with decreased low-density and high-density lipoprotein particle concentrations and increased GlycA, a pro-inflammatory glycoprotein biomarker.
    Berends AMA; Buitenwerf E; Gruppen EG; Sluiter WJ; Bakker SJL; Connelly MA; Kerstens MN; Dullaart RPF
    Clin Endocrinol (Oxf); 2019 Jan; 90(1):79-87. PubMed ID: 30372543
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association of Lipid, Inflammatory, and Metabolic Biomarkers With Age at Onset for Incident Coronary Heart Disease in Women.
    Dugani SB; Moorthy MV; Li C; Demler OV; Alsheikh-Ali AA; Ridker PM; Glynn RJ; Mora S
    JAMA Cardiol; 2021 Apr; 6(4):437-447. PubMed ID: 33471027
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High-density lipoprotein particle subclass heterogeneity and incident coronary heart disease.
    Akinkuolie AO; Paynter NP; Padmanabhan L; Mora S
    Circ Cardiovasc Qual Outcomes; 2014 Jan; 7(1):55-63. PubMed ID: 24248942
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Non-high-density lipoprotein and very-low-density lipoprotein cholesterol and their risk predictive values in coronary heart disease.
    Liu J; Sempos CT; Donahue RP; Dorn J; Trevisan M; Grundy SM
    Am J Cardiol; 2006 Nov; 98(10):1363-8. PubMed ID: 17134630
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance.
    Garvey WT; Kwon S; Zheng D; Shaughnessy S; Wallace P; Hutto A; Pugh K; Jenkins AJ; Klein RL; Liao Y
    Diabetes; 2003 Feb; 52(2):453-62. PubMed ID: 12540621
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Apolipoprotein B, Triglyceride-Rich Lipoproteins, and Risk of Cardiovascular Events in Persons with CKD.
    Lamprea-Montealegre JA; Staplin N; Herrington WG; Haynes R; Emberson J; Baigent C; de Boer IH;
    Clin J Am Soc Nephrol; 2020 Jan; 15(1):47-60. PubMed ID: 31831577
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies.
    ; Sarwar N; Sandhu MS; Ricketts SL; Butterworth AS; Di Angelantonio E; Boekholdt SM; Ouwehand W; Watkins H; Samani NJ; Saleheen D; Lawlor D; Reilly MP; Hingorani AD; Talmud PJ; Danesh J
    Lancet; 2010 May; 375(9726):1634-9. PubMed ID: 20452521
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Distribution of lipoproteins triglyceride and lipoprotein cholesterol in an adult population by age, sex, and hormone use- The Pacific Northwest Bell Telephone Company health survey.
    Wahl PW; Warnick GR; Albers JJ; Hoover JJ; Walden CE; Bergelin RO; Ogilvie JT; Hazzard WR; Knopp RH
    Atherosclerosis; 1981 Apr; 39(1):111-24. PubMed ID: 6941788
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Association of Lipids and Lipoproteins with Hip Fracture Risk: The Cardiovascular Health Study.
    Barzilay JI; Buzkova P; Kuller LH; Cauley JA; Fink HA; Sheets K; Robbins JA; Carbone LD; Elam RE; Mukamal KJ
    Am J Med; 2022 Sep; 135(9):1101-1108.e1. PubMed ID: 35679877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.